“…CNTN6 contains six N-terminal Ig-like and four fibronectin type III-like (FNIII) domains and tethers to the cell membrane via a C-terminal glycosylphosphatidylinositol (GPI)-anchor (Maness & Schachner, 2007;Shimoda & Watanabe, 2009;Zuko et al, 2013). Cntn6 has been identified as a candidate risk gene of multiple psychiatric disorders including autism spectrum disorders (ASDs), schizophrenia, bipolar disorder, attention-deficit hyperactivity disorder, intellectual disability, and Tourette syndrome (Guo et al, 2012;Hu et al, 2015;Huang et al, 2017;Kashevarova et al, 2014;Kerner, Lambert, & Muthen, 2011;Nava et al, 2014;Oguro-Ando, Zuko, Kleijer, & Burbach, 2017;Okbay et al, 2016;Pinto et al, 2010;Van Daalen et al, 2011), suggesting the necessity of CNTN6 in neural development.…”